SynCardia total artificial heart is currently approved as a bridge for the transplant of patients with end-stage heart failure affecting both ventricles.
SynCardia total artificial heart is currently approved as a bridge for the transplant of patients with end-stage heart failure affecting both ventricles.
Nuwellis is a medical device company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation.
CVRx is a medical device company that has developed proprietary implantable technology for the treatment of high blood pressure and heart failure.
HeartWare is an international company of ventricular assistance devices (VAD) which allows patients with heart failure return to life.
Última actualización 20 March, 2023